Where next in clinical asthma research? An innovative approach to research prioritisation by Hallsworth, M, Major, P, Barnes, N

Medical management of parapneumonic pleural disease. by Barnes, N, Hull, J, Thomson, A

Career Management Programmes for Academics in the Higher Education Sector: A RE-AIM Systematic Review by Barnes, N., Du Plessis, M., Frantz, J.

Get full text

Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis by Pavord, I, Lettis, S, Anzueto, A, Barnes, N

Assessment of the acceptability of a new salbutamol multidose dry powder inhaler (DPI) in patients with asthma by Morice, A, Stradling, JR, Barnes, N, Grp, C

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised by Pascoe, S, Pavord, I, Hinds, D, Locantore, N, Barnes, N

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids by Siddiqui, S, Pavord, I, Barnes, N, Guasconi, A, Lettis, S, Pascoe, S, Petruzzelli, S

Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler) for the treatment of adult asthma. Amsterdam Clinical Study Group. by Stradling, JR, Pearson, MG, Morice, A, Peake, MD, Barnes, N

Adhesive bowel obstruction? Not always by Mittapalli D, Sebastian B, Leung E, Barnes N, Senapati P S P

Get full text

Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. by Macfarlane, A, Dworski, R, Sheller, JR, Pavord, I, Kay, AB, Barnes, N

Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler (R)) for the treatment of adult asthma by Stradling, JR, Pearson, MG, Morice, A, Peake, MD, Barnes, N, Grp, A

The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world by Barnes N, Ishii T, Hizawa N, Midwinter D, James M, Hilton E, Jones PW

Get full text

Blood eosinophil levels as a biomarker in COPD by Brusselle, G, Pavord, I, Landis, S, Pascoe, S, Lettis, S, Morjaria, N, Barnes, N, Hilton, E

Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge. by Zeibecoglou, K, Macfarlane, A, Ying, S, Meng, Q, Pavord, I, Barnes, N, Robinson, D, Kay, AB

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. by Pavord, I, Jeffery, P, Qiu, Y, Zhu, J, Parker, D, Carlsheimer, A, Naya, I, Barnes, N

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol by Pascoe, S, Lipson, D, Locantore, N, Barnacle, H, Brealey, N, Mohindra, R, Dransfield, M, Pavord, I, Barnes, N

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. by Barnes, N, Qiu, Y, Pavord, I, Parker, D, Davis, P, Zhu, J, Johnson, M, Thomson, N, Jeffery, P

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD by Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Barnes N

Get full text

Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease by Collier DJ, Wielders P, van der Palen J, Heyes L, Midwinter D, Collison K, Preece A, Barnes N, Sharma R

Get full text

A randomized, open-label, single-visit crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD by van der Palen J, Moeskops-van Beurden W, Dawson CM, James WY, Preece A, Midwinter D, Barnes N, Sharma R

Get full text